ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Elotuzumab Biosimilar - Anti-SLAMF7 Antibody (PE) (A334231)

Recombinant humanized monoclonal antibody to SLAMF7 (PE) for Flow Cytometry.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Elotuzumab Biosimilar - Anti-SLAMF7 Antibody (PE)
Description
Recombinant humanized monoclonal antibody to SLAMF7 (PE).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Conjugate

PE

Excitation: 565nm, Emission: 578nm

Purification
Affinity chromatography.
Concentration
Lot Specific
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.05% Proclin 300 and 1% BSA.
Storage
Store at 4°C. Do not freeze!
Synonyms
CD2 subset 1, CD2-like receptor-activating cytotoxic cells, CD319, CRACC, CS1, Membrane protein FOAP-12, Novel Ly9, Protein 19A, SLAM family member 7
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Elotuzumab Biosimilar - Anti-SLAMF7 Antibody (PE) (A334231)? Please let us know so that we can list the citation on this page.

Proteins predicted to interact with SLAMF7

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
89.1% Relevancy Score
88% Relevancy Score
85.3% Relevancy Score
83.4% Relevancy Score
82.9% Relevancy Score
80.7% Relevancy Score
80% Relevancy Score
76.2% Relevancy Score
76.1% Relevancy Score